Pulse Biosciences (PLSE) Other financing activities (2016 - 2024)
Pulse Biosciences' quarterly Other financing activities came in at $59000.0 in Q4 2024, up 1083.33% year-on-year from $4985.9 in Q1 2024, and up 205.36% quarter-over-quarter from -$56000.0 in Q3 2024.
Pulse Biosciences has reported Other financing activities for 5 years, with the latest figure at $59000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other financing activities rose 1083.33% year-over-year to $59000.0; the trailing twelve-month figure through Dec 2025 stood at $3000.0 (changed 0.0% YoY), and the FY2024 full-year result was $281000.0, changed N/A from the prior year.
- Other financing activities for Q4 2024 stood at $59000.0, up from -$56000.0 in the prior quarter.
- The five-year high for Other financing activities was $59000.0 in Q4 2024, with the low at -$56000.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Pulse Biosciences | 1.72 Bn | 1.72 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 59,000.00 |
| Dec 31, 2024 | 59,000.00 |
| Sep 30, 2024 | -56,000.00 |
| Sep 30, 2024 | -56,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Mar 31, 2019 | 222,000.00 |
| Mar 31, 2019 | 222,000.00 |
| Mar 31, 2018 | 188,000.00 |
| Mar 31, 2018 | 188,000.00 |
| Sep 30, 2016 | 67,000.00 |
| Sep 30, 2016 | 67,000.00 |